PPT-Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

Beth Eaby Sandy MSN CRNP OCN Nurse Practitioner Abramson Cancer Center of the University of Pennsylvania Disclosure of Conflicts of Interest Beth Eaby Sandy MSN CRNP O CN . Brada. . Torino. . 6 March 2015. Perspectives in lung cancer. . Stereotactic ablative radiation therapy (. SABR). in patients with inoperable NSCLC. SABR in the context of modern radiotherapy of . E. . Rial-Sebbag. and A. . Blasimme. Outline. Presentation of cells therapies and of the legal and ethical tensions in using them.. Presentation of the . Durisotto. case. Discussion on the ruling of the European Court of Human . Gandara. , MD. University of California, Davis . Comprehensive Cancer Center. Biomarker-driven Phase III Clinical Trials: . Practical . & . Design Considerations. Clinical trial . d. esigns that define the. Insight Therapies. Relationship Therapies. Behavior Therapies. Cognitive Therapies. Biological Therapies . Evaluating the Therapies. Culture- and Gender- Sensitive Therapies. Why Seek Therapy?. Approaches to Therapy. Nathan Pennell, M.D., Ph.D.. September 6, 2014. Objectives. Discuss the role of chemotherapy in molecularly defined populations. Discuss the addition of chemo and/or bevacizumab (Avastin) to targeted therapy. Renato G. Martins, MD, MPH. Medical Director, Thoracic/Head and Neck; General Oncology and Hematology. Seattle Cancer Care Alliance. July 28, 2015. 11:30 am – 12:30 pm, EST. ICLIO e-Course 02. Objectives. Medical Director, Heart Failure and Cardiac Transplant Program. University of Pennsylvania. What Are Advanced Therapies?. Heart Transplant. Ventricular Assisted Devices (VAD). Mechanical Circulatory Support (MCS). Over the ages, a mix of treatments and . methods . have. been attempted . to . treat people . with . psychological. disorders. Treatments . have. ranged . from harsh to gentle. Reformers. Philippe . What are the different types of therapy?. How does each type address cause of behavior and focus of treatment. . Think of a Bad Habit you have…. How would you acquire it using the following approaches? . actual. . video-recorded proceedings from the . live . CME event and may include the use of trade names and other raw, unedited content. . Disclosures for . Dr. Langer. Advisory Committee. Abbott Laboratories, AstraZeneca Pharmaceuticals LP, . Interview with Shirish M . Gadgeel. , MD . January 14, 2020. Case 1: 72-year-old woman enrolled on KEYNOTE-021. 2014: 72-year-old female patient with chest pain, cough and dyspnea is diagnosed with Stage IV squamous cell carcinoma. Abramson Cancer Center . University of Pennsylvania. Philadelphia, Pennsylvania. Keeping Up in NSCLC: Actionable Biomarkers and Their Impact on Treatment. Rasheda Persinger, MSN, AGNP-C, AOCNP. Lead Nurse Practitioner. Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum. Friday, October 11, 2019. 6:15 PM – 7:45 PM . Chicago, Illinois. Faculty. . Moderator. Joel W Neal, MD, PhD. Nasser H Hanna, MD. Professor Rachel Butler. The genomic complexity of advanced NSCLC. Jordan et al. Cancer Discovery (2017). >50% NSCLC now have actionable variant. Treatment algorithm. NHSE: National Genomic Test Directory.